Navigation Links
New findings come to light about monkeypox

The monkeypox virus, which had attacked 72 people in US in 2003 in an outbreak// of the disease, did not kill anybody, although it is considered to be fatal disease. A new research unveils that these cases were amongst the few strains of the virus that are not fatal.

Monkeypox is a very rare viral disease said to originate from African continent. It had been so named because it was first identified in monkeys in the laboratory. The symptoms of the disease are usually similar to smallpox, but are mild by nature. However unlike smallpox, this condition causes the lymph glands to swell.

In 2003 there were cases of monkeypox reported in US where the people got infected from the pet dogs that had carried the virus home from other animals.

Researchers for the study had suggested that evidence points out to the strain of virus that had traveled half the globe came from West Africa. This was one of the less virulent virus strains and had been seen in the western world for the first time. One of the reasons for the virus which primarily infects the animals is seen to affect the humans is the fact that human habitats are increasingly encroaching into animal habitat leading to the spread of diseases from the animals to the humans and vice versa.

Reference: Virology, July 2005
'"/>




Page: 1

Related medicine news :

1. Fat findings
2. New findings, throw light on obesity
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
5. Hazards of sunlight
6. Slightly High BP Poses Health Risk
7. Arterial stiffness prevented by light drinking
8. New light on Cardiology
9. Diet, Sunlight connected to Breast Cancer Risk
10. Dangers of sunlight
11. A ray of light on Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: